Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMEREN CORPAEE · Entity 3150 | Chmn & President of Subsidiary | March 31, 2022 | April 04, 2022 |
| SEMPRASRE · Entity 3017 | Director | October 01, 2026 | October 02, 2026 |
| TENET HEALTHCARE CORPTHC · Entity 2563 | Director | September 10, 2026 | September 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMEREN CORP
Report date March 31, 2022 · Filed April 04, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $.01 Par ValueSEC Table I · non-derivative | Direct | 144,165 |
Reported balance
After 2022-03-31 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2022-03-31 · Sale · Disposed 6,000 · Balance 144,165 F2: Shares sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3: Amount includes 75 accrued dividend equivalents acquired during the first quarter of 2022 pursuant to a dividend reinvestment feature of restricted stock units granted under the issuer's 2014 Omnibus Incentive Compensation Plan. |
| Common Stock, $.01 Par ValueSEC Table I · non-derivative | IndirectBy 401(K) | 14,077 |
Reported balance
Holding disclosure · report date 2022-03-31 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 14,077 F1: Represents the estimated number of share equivalents held by the reporting person in the unitized stock fund included in the Ameren Corporation Savings Investment Plan as of March 31, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the estimated number of share equivalents held by the reporting person in the unitized stock fund included in the Ameren Corporation Savings Investment Plan as of March 31, 2022.
F2: Shares sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F3: Amount includes 75 accrued dividend equivalents acquired during the first quarter of 2022 pursuant to a dividend reinvestment feature of restricted stock units granted under the issuer's 2014 Omnibus Incentive Compensation Plan.
SEMPRA
Report date October 01, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom SharesSEC Table II · derivative / convertible security | Direct | 2,179.13 |
Reported balance
After 2026-10-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 160.15 · Balance 2,179.13 F1: Phantom shares of Sempra Common Stock acquired as director compensation. F2: Conversion of Derivative Security is 1 for 1. F3: Date exercisable is immediate for shares that have vested. F4: Expiration date is Not Applicable. |
Filing footnotes · ownership attribution and instrument terms
F1: Phantom shares of Sempra Common Stock acquired as director compensation.
F2: Conversion of Derivative Security is 1 for 1.
F3: Date exercisable is immediate for shares that have vested.
F4: Expiration date is Not Applicable.
TENET HEALTHCARE CORP
Report date September 10, 2026 · Filed September 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,121 |
Reported balance
After 2026-09-10 transaction · row 1
1 source rowRow 1 · 2026-09-10 · Sale · Disposed 10,000 · Balance 25,121 F1: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $263.15 to $264.03. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $263.15 to $264.03. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 2, 2026 21:22 UTC | SEMPRA SRE · Entity 3017 | GrantPhantom Shares · Derivative | 160.15 | $78.05 | $12,499.71 |
DisclosureSEC source: 0001190100-26-000012 · wk-form4_1790976143.xml · derivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,179.13 Underlying: Common Stock · 160.15 shares Expires not disclosed F1 · security: Phantom shares of Sempra Common Stock acquired as director compensation. F2 · derivative.exercise_price: Conversion of Derivative Security is 1 for 1. F3 · derivative.exercise_date: Date exercisable is immediate for shares that have vested. F4 · derivative.expiration_date: Expiration date is Not Applicable. Read SEC document |
| September 10, 2026 Filed Sep 15, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 10,000 | $263.42 | $2,634,200.00 |
DisclosureSEC source: 0001193125-26-391004 · ownership.xml · nonDerivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,121 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $263.15 to $264.03. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:10 UTC | SEMPRA SRE · Entity 3017 | GrantPhantom Shares · Derivative | 136.81 | $91.37 | $12,500.33 |
DisclosureSEC source: 0001190100-26-000010 · wk-form4_1783023013.xml · derivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,005.78 Underlying: Common Stock · 136.81 shares Expires not disclosed F1 · security: Phantom shares of Sempra Common Stock acquired as director compensation. F2 · derivative.exercise_price: Conversion of Derivative Security is 1 for 1. F3 · derivative.exercise_date: Date exercisable is immediate for shares that have vested. F4 · derivative.expiration_date: Expiration date is Not Applicable. Read SEC document |
| May 27, 2026 Filed May 29, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Grant2026 May Restricted Stock Units · Derivative | 1,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-245812 · ownership.xml · derivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,188 Underlying: Common Stock · 1,188 shares Expires 2027-05-27 F1 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2025 May Restricted Stock Units · Derivative | 1,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-239936 · ownership.xml · derivative · entry 3 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,333 shares Expires 2026-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock. Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Disposition to issuerCommon Stock | 493 | $173.78 | $85,673.54 |
DisclosureSEC source: 0001193125-26-239936 · ownership.xml · nonDerivative · entry 2 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,121 Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 1,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-239936 · ownership.xml · nonDerivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock. Read SEC document |
| May 12, 2026 Filed May 13, 2026 23:42 UTC | SEMPRA SRE · Entity 3017 | GrantCommon Stock | 1,499 | $0.00 | $0.00 |
DisclosureSEC source: 0001190100-26-000007 · wk-form4_1778715735.xml · nonDerivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,913.45 Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 23:25 UTC | SEMPRA SRE · Entity 3017 | GrantPhantom Shares · Derivative | 128.32 | $97.41 | $12,499.65 |
DisclosureSEC source: 0001190100-26-000005 · wk-form4_1775172311.xml · derivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,857.1 Underlying: Common Stock · 128.32 shares Expires not disclosed F1 · security: Phantom shares of Sempra Common Stock acquired as director compensation. F2 · derivative.exercise_price: Conversion of Derivative Security is 1 for 1. F3 · derivative.exercise_date: Date exercisable is immediate for shares that have vested. F4 · derivative.expiration_date: Expiration date is Not Applicable. Read SEC document |
| March 11, 2026 Filed Mar 11, 2026 23:19 UTC | SEMPRA SRE · Entity 3017 | PurchaseCommon Stock | 2,692 | $93.30 | $251,163.60 |
DisclosureSEC source: 0001190100-26-000004 · wk-form4_1773271142.xml · nonDerivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,375.99 Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 00:33 UTC | SEMPRA SRE · Entity 3017 | GrantPhantom Shares · Derivative | 139.34 | $89.71 | $12,500.19 |
DisclosureSEC source: 0001190100-26-000002 · wk-form4_1767659588.xml · derivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,717.71 Underlying: Common Stock · 139.34 shares Expires not disclosed F1 · security: Phantom shares of Sempra Common Stock acquired as director compensation. F2 · derivative.exercise_price: Conversion of Derivative Security is 1 for 1. F3 · derivative.exercise_date: Date exercisable is immediate for shares that have vested. F4 · derivative.expiration_date: Expiration date is Not Applicable. Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 22:01 UTC | SEMPRA SRE · Entity 3017 | GrantPhantom Shares · Derivative | 140.04 | $89.26 | $12,499.97 |
DisclosureSEC source: 0001190100-25-000004 · wk-form4_1759442460.xml · derivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,567.4 Underlying: Common Stock · 140.04 shares Expires not disclosed F1 · security: Phantom shares of Sempra Common Stock acquired as director compensation. F2 · derivative.exercise_price: Conversion of Derivative Security is 1 for 1. F3 · derivative.exercise_date: Date exercisable is immediate for shares that have vested. F4 · derivative.expiration_date: Expiration date is Not Applicable. Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 21:38 UTC | SEMPRA SRE · Entity 3017 | GrantPhantom Shares · Derivative | 164.09 | $76.18 | $12,500.38 |
DisclosureSEC source: 0001062993-25-012499 · form4.xml · derivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,416.45 Underlying: Common Stock · 164.09 shares Expires not disclosed F1 · security: Phantom shares of Sempra Common Stock acquired as director compensation. F2 · derivative.exercise_price: Conversion of Derivative Security is 1 for 1. F3 · derivative.exercise_date: Date exercisable is immediate for shares that have vested. F4 · derivative.expiration_date: Expiration date is Not Applicable. Read SEC document |
| May 23, 2025 Filed May 28, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionRestricted Stock Units · Derivative | 1,551 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-078018 · ownership.xml · derivative · entry 4 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,551 shares Expires 2025-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock. Read SEC document |
| May 23, 2025 Filed May 28, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Disposition to issuerCommon Stock | 573 | $161.33 | $92,442.09 |
DisclosureSEC source: 0000950170-25-078018 · ownership.xml · nonDerivative · entry 2 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,281 Read SEC document |
| May 23, 2025 Filed May 28, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 1,551 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-078018 · ownership.xml · nonDerivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock. Read SEC document |
| May 22, 2025 Filed May 28, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantRestricted Stock Units · Derivative | 1,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-078018 · ownership.xml · derivative · entry 3 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,333 Underlying: Common Stock · 1,333 shares Expires 2026-05-22 F2 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| May 13, 2025 Filed May 15, 2025 00:24 UTC | SEMPRA SRE · Entity 3017 | GrantCommon Stock | 1,864 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-009426 · form4.xml · nonDerivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,558.72 Read SEC document |
| May 13, 2025 Filed May 15, 2025 00:23 UTC | SEMPRA SRE · Entity 3017 | GrantCommon Stock | 1,864 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-009424 · form4.xml · nonDerivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,558.72 Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 22:21 UTC | SEMPRA SRE · Entity 3017 | GrantPhantom Shares · Derivative | 174.68 | $71.56 | $12,500.10 |
DisclosureSEC source: 0001062993-25-006887 · form4.xml · derivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,242.54 Underlying: Common Stock · 174.68 shares Expires not disclosed F1 · security: Phantom shares of Sempra Common Stock acquired as director compensation. F2 · derivative.exercise_price: Conversion of Derivative Security is 1 for 1. F3 · derivative.exercise_date: Date exercisable is immediate for shares that have vested. F4 · derivative.expiration_date: Expiration date is Not Applicable. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:08 UTC | SEMPRA SRE · Entity 3017 | PurchaseCommon Stock | 7,160 | $69.81 | $499,839.60 |
DisclosureSEC source: 0001062993-25-004954 · form4.xml · nonDerivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,661.81 Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 22:21 UTC | SEMPRA SRE · Entity 3017 | GrantPhantom Shares · Derivative | 143.46 | $87.13 | $12,499.67 |
DisclosureSEC source: 0001062993-25-000252 · form4.xml · derivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,060.95 Underlying: Common Stock · 143.46 shares Expires not disclosed F1 · security: Phantom shares of Sempra Common Stock acquired as director compensation. F2 · derivative.exercise_price: Conversion of Derivative Security is 1 for 1. F3 · derivative.exercise_date: Date exercisable is immediate for shares that have vested. F4 · derivative.expiration_date: Expiration date is Not Applicable. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 22:12 UTC | SEMPRA SRE · Entity 3017 | GrantPhantom Shares · Derivative | 148.95 | $83.92 | $12,499.88 |
DisclosureSEC source: 0001062993-24-017314 · form4.xml · derivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 911.84 Underlying: Common Stock · 148.95 shares Expires not disclosed F1 · security: Phantom shares of Sempra Common Stock acquired as director compensation. F2 · derivative.exercise_price: Conversion of Derivative Security is 1 for 1. F3 · derivative.exercise_date: Date exercisable is immediate for shares that have vested. F4 · derivative.expiration_date: Expiration date is Not Applicable. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 21:04 UTC | SEMPRA SRE · Entity 3017 | GrantPhantom Shares · Derivative | 166.73 | $74.97 | $12,499.75 |
DisclosureSEC source: 0001062993-24-013352 · form4.xml · derivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 758.1 Underlying: Common Stock · 166.73 shares Expires not disclosed F1 · security: Phantom shares of Sempra Common Stock acquired as director compensation. F2 · derivative.exercise_price: Conversion of Derivative Security is 1 for 1. F3 · derivative.exercise_date: Date exercisable is immediate for shares that have vested. F4 · derivative.expiration_date: Expiration date is Not Applicable. Read SEC document |
| May 23, 2024 Filed May 29, 2024 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantRestricted Stock Units · Derivative | 1,551 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-065557 · ownership.xml · derivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,551 Underlying: Common Stock · 1,551 shares Expires 2025-05-23 F1 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| May 17, 2024 Filed May 17, 2024 23:22 UTC | SEMPRA SRE · Entity 3017 | PurchaseCommon Stock | 1,925 | $77.97 | $150,092.25 |
DisclosureSEC source: 0001062993-24-010718 · form4.xml · nonDerivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,420.31 Read SEC document |
| May 09, 2024 Filed May 13, 2024 19:22 UTC | SEMPRA SRE · Entity 3017 | GrantCommon Stock | 1,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-010032 · form4.xml · nonDerivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,495.31 Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 21:15 UTC | SEMPRA SRE · Entity 3017 | GrantPhantom Shares · Derivative | 175.17 | $71.36 | $12,500.13 |
DisclosureSEC source: 0001062993-24-007754 · form4.xml · derivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 587.61 Underlying: Common Stock · 175.17 shares Expires not disclosed F1 · security: Phantom shares of Sempra Common Stock acquired as director compensation. F2 · derivative.exercise_price: Conversion of Derivative Security is 1 for 1. F3 · derivative.exercise_date: Date exercisable is immediate for shares that have vested. F4 · derivative.expiration_date: Expiration date is Not Applicable. Read SEC document |
| March 12, 2024 Filed Mar 15, 2024 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 14,000 | $98.98 | $1,385,720.00 |
DisclosureSEC source: 0000950170-24-031800 · ownership.xml · nonDerivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,303 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $98.81 to $99.20. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 00:39 UTC | SEMPRA SRE · Entity 3017 | GrantPhantom Shares · Derivative | 164.86 | $75.82 | $12,499.69 |
DisclosureSEC source: 0001062993-24-000297 · form4.xml · derivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410.5 Underlying: Common Stock · 164.86 shares Expires not disclosed F1 · security: Phantom shares of Sempra Common Stock acquired as director compensation. F2 · derivative.exercise_price: Conversion of Derivative Security is 1 for 1. F3 · derivative.exercise_date: Date exercisable is immediate for shares that have vested. F4 · derivative.expiration_date: Expiration date is Not Applicable. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 00:27 UTC | SEMPRA SRE · Entity 3017 | GrantPhantom Shares · Derivative | 245.64 | $65.27 | $16,032.92 |
DisclosureSEC source: 0001062993-23-018925 · form4.xml · derivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 245.64 Underlying: Common Stock · 245.64 shares Expires not disclosed F1 · security: Phantom shares of Sempra Common Stock acquired as director compensation. F2 · derivative.exercise_price: Conversion of Derivative Security is 1 for 1. F3 · derivative.exercise_date: Date exercisable is immediate for shares that have vested. F4 · derivative.expiration_date: Expiration date is Not Applicable. Read SEC document |
| September 05, 2023 Filed Sep 6, 2023 21:39 UTC | SEMPRA SRE · Entity 3017 | GrantCommon Stock | 1,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017725 · form4.xml · nonDerivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,807 Read SEC document |
| May 26, 2023 Filed May 30, 2023 21:35 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 2,846 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032954 · doc4.xml · nonDerivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,467 F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). Read SEC document |
| May 26, 2023 Filed Jun 23, 2023 23:29 UTC Amendment | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 3,682 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-039552 · doc4a.xml · nonDerivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,303 F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F2 · shares: This amendment is being filed to correct the amount of restricted stock units granted on May 26, 2023. Read SEC document |
| May 09, 2022 Filed May 11, 2022 21:01 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 3,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028347 · doc4.xml · nonDerivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,621 F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 23:12 UTC | AMEREN CORP AEE · Entity 3150 | SaleCommon Stock, $.01 Par Value | 6,000 | $93.67 | $562,020.00 |
DisclosureSEC source: 0001002910-22-000057 · wf-form4_164911393900012.xml · nonDerivative · entry 2 MARK RICHARD J · CIK 0001190100 · Chmn & President of Subsidiary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,165 F2 · shares: Shares sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · balance_after: Amount includes 75 accrued dividend equivalents acquired during the first quarter of 2022 pursuant to a dividend reinvestment feature of restricted stock units granted under the issuer's 2014 Omnibus Incentive Compensation Plan. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 21:00 UTC | AMEREN CORP AEE · Entity 3150 | SaleCommon Stock, $.01 Par Value | 3,500 | $87.37 | $305,795.00 |
DisclosureSEC source: 0001002910-22-000053 · wf-form4_164729149175632.xml · nonDerivative · entry 2 MARK RICHARD J · CIK 0001190100 · Chmn & President of Subsidiary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,091 Read SEC document |
| March 09, 2022 Filed Mar 10, 2022 22:15 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 6,000 | $90.47 | $542,820.00 |
DisclosureSEC source: 0001209191-22-017997 · doc4.xml · nonDerivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,785 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $90.43 to $90.50. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 21:53 UTC | AMEREN CORP AEE · Entity 3150 | Tax withholdingCommon Stock, $.01 Par Value | 7,205 | $85.95 | $619,269.75 |
DisclosureSEC source: 0001002910-22-000044 · wf-form4_164625798180421.xml · nonDerivative · entry 3 MARK RICHARD J · CIK 0001190100 · Chmn & President of Subsidiary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,586 F4 · shares: Shares withheld by the issuer to satisfy tax withholding obligations arising in connection with the vesting of performance share units and restricted stock units. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 02:53 UTC | AMEREN CORP AEE · Entity 3150 | GrantCommon Stock, $.01 Par Value | 3,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001002910-22-000033 · wf-form4_164489355377769.xml · nonDerivative · entry 3 MARK RICHARD J · CIK 0001190100 · Chmn & President of Subsidiary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,791 F3 · shares: These restricted stock units were granted under the issuer's 2014 Omnibus Incentive Compensation Plan and are scheduled to vest upon the payment date in 2025, which shall be no later than March 15, 2025, subject to the terms of the Plan and the applicable award agreement issued thereunder. F4 · balance_after: Amount includes 89 shares acquired through reinvested dividends during the second through fourth quarters of 2021, as well as 231 accrued dividend equivalents acquired during the second through fourth quarters of 2021 pursuant to a dividend reinvestment feature of restricted stock units granted under the Plan. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 02:53 UTC | AMEREN CORP AEE · Entity 3150 | GrantCommon Stock, $.01 Par Value | 14,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001002910-22-000033 · wf-form4_164489355377769.xml · nonDerivative · entry 2 MARK RICHARD J · CIK 0001190100 · Chmn & President of Subsidiary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,066 F2 · shares: Shares acquired upon vesting of previously granted performance share units. Read SEC document |
| September 30, 2021 Filed Mar 2, 2022 21:53 UTC | AMEREN CORP AEE · Entity 3150 | SaleCommon Stock, $.01 Par Value | 6,000 | $82.18 | $493,080.00 |
DisclosureSEC source: 0001002910-22-000044 · wf-form4_164625798180421.xml · nonDerivative · entry 2 MARK RICHARD J · CIK 0001190100 · Chmn & President of Subsidiary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,791 F2 · shares: Shares sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.92 to $82.28, inclusive. The reporting person undertakes to provide Ameren Corporation (Ameren), any security holder of Ameren, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| May 07, 2021 Filed May 11, 2021 22:02 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 3,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-031819 · doc4.xml · nonDerivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,785 F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 20:11 UTC | AMEREN CORP AEE · Entity 3150 | SaleCommon Stock, $.01 Par Value | 6,000 | $81.17 | $487,020.00 |
DisclosureSEC source: 0001002910-21-000092 · wf-form4_161739425812657.xml · nonDerivative · entry 2 MARK RICHARD J · CIK 0001190100 · Chmn & President of Subsidiary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,566 F2 · shares: Shares sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported above reflects the weighted average sale price. The shares were sold at multiple prices ranging from $81.13 to $81.45. The reporting person undertakes to provide full information regarding the number of shares and prices at which the transaction was effected upon request by the staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer. F4 · balance_after: Amount includes an additional 9 shares acquired through monthly payroll deductions and 29 shares acquired through reinvested dividends during the first quarter of 2021, as well as 86 accrued dividend equivalents acquired during the first quarter of 2021 pursuant to a dividend reinvestment feature of restricted stock units granted under the issuer's 2014 Omnibus Incentive Compensation Plan. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:37 UTC | AMEREN CORP AEE · Entity 3150 | Tax withholdingCommon Stock, $.01 Par Value | 15,552 | $70.27 | $1,092,839.04 |
DisclosureSEC source: 0001002910-21-000082 · wf-form4_161472101358356.xml · nonDerivative · entry 2 MARK RICHARD J · CIK 0001190100 · Chmn & President of Subsidiary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,442 F2 · shares: Shares withheld by the issuer to satisfy tax withholding obligations arising in connection with the vesting of performance share units and restricted stock units. F3 · balance_after: Amount includes 4 shares acquired in February 2021 through monthly payroll deductions. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 21:52 UTC | AMEREN CORP AEE · Entity 3150 | GrantCommon Stock, $.01 Par Value | 18,609 | $0.00 | $0.00 |
DisclosureSEC source: 0001002910-21-000056 · wf-form4_161351230612548.xml · nonDerivative · entry 2 MARK RICHARD J · CIK 0001190100 · Chmn & President of Subsidiary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,990 F2 · shares: Shares acquired upon vesting of previously granted performance share units. F3 · balance_after: Amount includes 8 shares acquired in 2021 through monthly payroll deductions. Read SEC document |
| January 02, 2021 Filed Jan 6, 2021 02:43 UTC | AMEREN CORP AEE · Entity 3150 | GrantCommon Stock, $.01 Par Value | 3,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001002910-21-000050 · wf-form4_160990098506625.xml · nonDerivative · entry 2 MARK RICHARD J · CIK 0001190100 · Chmn & President of Subsidiary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,373 F2 · shares: These restricted stock units were granted under the issuer's 2014 Omnibus Incentive Compensation Plan (the "Plan") and are scheduled to vest upon the payment date in 2024, which shall be no later than March 15, 2024, subject to the terms of the Plan and the applicable award agreement issued thereunder. F3 · balance_after: Amount includes 797 shares acquired during the fourth quarter of 2020 through monthly payroll deductions and reinvested dividends, as well as 187 accrued dividend equivalents acquired during the fourth quarter of 2020 pursuant to a dividend reinvestment feature of restricted stock units granted under the issuer's 2014 Omnibus Incentive Compensation Plan. Read SEC document |
| November 19, 2020 Filed Nov 24, 2020 01:33 UTC | AMEREN CORP AEE · Entity 3150 | SaleCommon Stock, $.01 Par Value | 6,300 | $78.00 | $491,400.00 |
DisclosureSEC source: 0001002910-20-000142 · wf-form4_160618161321785.xml · nonDerivative · entry 2 MARK RICHARD J · CIK 0001190100 · Chmn & President of Subsidiary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,684 F2 · balance_after: Amount includes an additional 46 shares acquired through monthly payroll deductions and 1,637 shares acquired through reinvested dividends in 2020, as well as 364 accrued dividend equivalents acquired during 2020 pursuant to a dividend reinvestment feature of restricted stock units granted under the issuer's 2014 Omnibus Incentive Compensation Plan. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 20:17 UTC | AMEREN CORP AEE · Entity 3150 | GiftCommon Stock, $.01 Par Value | 199 | $0.00 | $0.00 |
DisclosureSEC source: 0001002910-20-000122 · wf-form4_159173382926596.xml · nonDerivative · entry 2 MARK RICHARD J · CIK 0001190100 · Chmn & President of Subsidiary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,937 F2 · shares: Shares donated as a charitable gift. F3 · balance_after: Amount includes an additional 21 shares acquired through monthly payroll deductions and 809 shares acquired through reinvested dividends in 2020, as well as 167 accrued dividend equivalents acquired during 2020 pursuant to a dividend reinvestment feature of restricted stock units granted under the issuer's 2014 Omnibus Incentive Compensation Plan. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 23:19 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 11,139 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-033755 · doc4.xml · nonDerivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,825 F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.